InvestorsHub Logo
icon url

stoneroad

02/25/19 5:28 PM

#177727 RE: MNBioMike #177725

That’s actually an excellent point.
icon url

biowreck

02/25/19 5:42 PM

#177731 RE: MNBioMike #177725

Except you would have another secondary to pay the hundreds of new employees....
icon url

massulo52

02/25/19 5:56 PM

#177733 RE: MNBioMike #177725

This makes crystal sense.
icon url

funnygi2

02/25/19 7:59 PM

#177761 RE: MNBioMike #177725

Then why are they doubling their office space effective July 2019 to the size of a "football field"?
icon url

BioBS2012

02/25/19 9:43 PM

#177771 RE: MNBioMike #177725

Given that the company has been selling Vascepa for a few years now not sure why one would expect more non-sales positions.
It is not unreasonable to expect existing suppliers to crank out more product. People handling that supply chain already exist
The accounting folks can surely handle the additional “katching” sound
Sales they have added more for now
Really need minimal additional nonsales personnel to get to a Billion in sales.
As sales ramp up they can assess and see where it makes most sense to add personnel
IMO management has been very prudent thus far and one can expect the same to continue